Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Medical Genetics · Trisomy X

Genetics and Diagnosis of Trisomy X

At a Glance

Trisomy X is typically caused by a random genetic event called nondisjunction. If you received a high-risk result from an NIPT, remember it is only a screening and false positives are common. Guidelines strongly recommend confirming any NIPT result with a diagnostic test like amniocentesis.

Understanding the genetics of Trisomy X often begins with the word nondisjunction. This is the biological “glitch” responsible for the presence of an extra chromosome. To navigate this diagnosis, it is essential to understand how it happens, how it is found, and what terms like “mosaicism” actually mean for you or your child.

The Biology of Nondisjunction

In most cases, Trisomy X is the result of nondisjunction—a random event where a pair of X chromosomes fails to separate properly during the creation of an egg or sperm [1].

  • A Random Event: When this happens, the resulting embryo has three X chromosomes (47, XXX) instead of the typical two (46, XX).
  • Maternal Age: While this can happen in any pregnancy, research shows that the risk of nondisjunction increases as a woman ages [2][3]. This is partly due to the natural aging process of the proteins that hold chromosomes together in the egg [4][5].
  • Not Your Fault: It is important to emphasize that nondisjunction is a spontaneous biological error. There is nothing a parent did before or during pregnancy to cause it.

Screening vs. Diagnosis and PPV

Many families first learn about Trisomy X through Non-Invasive Prenatal Testing (NIPT). However, there is a massive difference between a screen and a diagnostic test.

Test Type Examples Purpose Accuracy & PPV
Screening NIPT (cfDNA) To identify “high risk” pregnancies [6]. High sensitivity, but prone to false positives for sex chromosomes [7][8].
Diagnostic Amniocentesis, CVS, Postnatal Karyotype To provide a definitive “yes” or “no” answer [9]. Extremely accurate; the “gold standard” for diagnosis [10].

Understanding Positive Predictive Value (PPV): It is crucial to understand that a positive NIPT does not equal a 100% certainty. The PPV for sex chromosome aneuploidies like Trisomy X is often lower than for conditions like Down syndrome [7]. Depending on the specific test and maternal age, the chance of a false positive can be quite high, meaning there is a significant statistical chance the baby does not have the condition. Genetic counselors often use online PPV calculators to help parents understand their specific, personalized risk.

Why False Positives Happen: An NIPT tests DNA from the placenta, not directly from the fetus. Sometimes the placenta has an extra X chromosome while the baby does not (this is called confined placental mosaicism) [11][12]. Additionally, if the mother herself has an extra X chromosome she doesn’t know about, it can cause a “false” positive for the baby [12][13].

Understanding Mosaicism

While most girls have the extra X in every cell, some have mosaicism (often written as 46,XX/47,XXX).

  • The Mechanism: Unlike typical Trisomy X, mosaicism usually happens after conception (post-zygotic). As the embryo’s cells divide, a “mistake” occurs in one cell line, leading to some cells having 46 chromosomes and others having 47 [1].
  • The “Milder” Phenotype: Because a portion of the body’s cells are typical (46, XX), individuals with mosaicism often have milder physical or developmental symptoms than those with non-mosaic Trisomy X [14][3].
  • Tissue Variability: Sometimes the percentage of mosaic cells is different in different parts of the body (like the blood versus the skin), which is why symptoms can be so varied [15].

Current Guidelines

Major medical organizations, including ACOG (American College of Obstetricians and Gynecologists) and ACMG (American College of Medical Genetics and Genomics), now recommend that NIPT be offered to all pregnant patients [16][6]. However, they strongly advise that any positive NIPT result for a sex chromosome variation must be confirmed with a diagnostic test like an amniocentesis before making any permanent healthcare decisions [8][17]. Areas of concern or positive results should always be discussed with a genetic counselor [18].

Common questions in this guide

What is the difference between an NIPT screen and a diagnostic test for Trisomy X?
An NIPT is a screening test that evaluates placental DNA to find high-risk pregnancies, but it can have false positives. A diagnostic test, like an amniocentesis or karyotype, evaluates the baby's actual cells to provide a definitive yes or no answer.
Why might an NIPT give a false positive for Trisomy X?
False positives can occur if the extra X chromosome is only in the placenta, a condition called confined placental mosaicism. They can also happen if the mother herself has an undiagnosed extra X chromosome.
What causes Trisomy X?
Most cases are caused by a random biological event called nondisjunction, where X chromosomes fail to separate properly during the creation of an egg or sperm. It is a spontaneous error and is not caused by anything a parent did before or during pregnancy.
What does Trisomy X mosaicism mean?
Mosaicism, written as 46,XX/47,XXX, means that some of the body's cells have the typical two X chromosomes while others have three. Individuals with mosaicism often experience milder symptoms because a portion of their cells are unaffected by the extra chromosome.
Should a positive NIPT result for Trisomy X be confirmed?
Yes, major medical guidelines strongly recommend confirming a positive NIPT result with a diagnostic test like an amniocentesis before making any medical decisions. An NIPT alone is not enough to confirm a diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was the original test an NIPT screening or a diagnostic karyotype?
  2. 2.Can you walk me through the Positive Predictive Value (PPV) of my specific NIPT result?
  3. 3.Should I (the mother) have a karyotype test to see if maternal mosaicism might be affecting the NIPT results?
  4. 4.Does my (or my child's) mosaicism percentage mean anything specific for our long-term expectations?
  5. 5.Is there a difference in how we should monitor 46,XX/47,XXX mosaicism versus non-mosaic Trisomy X?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Sex chromosome aneuploidies.

    Skuse D, Printzlau F, Wolstencroft J

    Handbook of clinical neurology 2018; (147()):355-376 doi:10.1016/B978-0-444-63233-3.00024-5.

    PMID: 29325624
  2. 2

    A finding in genetic polymorphism analysis study: A case of non-mosaic 47, XXX without manifestations.

    Yang X, Ye Z, Zhang X, et al.

    Legal medicine (Tokyo, Japan) 2017; (27()):38-42 doi:10.1016/j.legalmed.2017.06.006.

    PMID: 28697408
  3. 3

    Noninvasive prenatal testing for assessing foetal sex chromosome aneuploidy: a retrospective study of 45,773 cases.

    Lu X, Wang C, Sun Y, et al.

    Molecular cytogenetics 2021; (14(1)):1 doi:10.1186/s13039-020-00521-2.

    PMID: 33407708
  4. 4

    Age-Related Loss of Cohesion: Causes and Effects.

    Cheng JM, Liu YX

    International journal of molecular sciences 2017; (18(7)) doi:10.3390/ijms18071578.

    PMID: 28737671
  5. 5

    Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging.

    Capalbo A, Hoffmann ER, Cimadomo D, et al.

    Human reproduction update 2017; (23(6)):706-722 doi:10.1093/humupd/dmx026.

    PMID: 28961822
  6. 6

    Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

    Dungan JS, Klugman S, Darilek S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2023; (25(2)):100336 doi:10.1016/j.gim.2022.11.004.

    PMID: 36524989
  7. 7

    Performance of noninvasive prenatal screening for fetal sex chromosome aneuploidies in a cohort of 116,862 pregnancies.

    Xu Y, Lou J, Qian Y, et al.

    Expert review of molecular diagnostics 2024; (24(5)):467-472 doi:10.1080/14737159.2024.2333951.

    PMID: 38526221
  8. 8

    Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma.

    Wang Y, Li S, Wang W, et al.

    Molecular cytogenetics 2020; (13()):10 doi:10.1186/s13039-020-0478-5.

    PMID: 32190123
  9. 9

    The Impact of Chromosomal Mosaicisms on Prenatal Diagnosis and Genetic Counseling-A Narrative Review.

    Militaru MS, Babliuc IM, Bloaje-Florică VL, et al.

    Journal of personalized medicine 2024; (14(7)) doi:10.3390/jpm14070774.

    PMID: 39064028
  10. 10

    The Necessity of Prenatal Diagnosis by CMA for the Women with NIPS-Positive Results.

    Xu J, Xue Y, Wang J, et al.

    International journal of genomics 2020; (2020()):2145701 doi:10.1155/2020/2145701.

    PMID: 32953872
  11. 11

    Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform.

    Tian Y, Zhang L, Tian W, et al.

    Molecular cytogenetics 2018; (11()):49 doi:10.1186/s13039-018-0397-x.

    PMID: 30159034
  12. 12

    Relationships among maternal monosomy X mosaicism, maternal trisomy, and discordant sex chromosome aneuploidies.

    Tang X, Du Y, Chen M, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (554()):117770 doi:10.1016/j.cca.2024.117770.

    PMID: 38199578
  13. 13

    Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.

    Bianchi DW, Chudova D, Sehnert AJ, et al.

    JAMA 2015; (314(2)):162-9 doi:10.1001/jama.2015.7120.

    PMID: 26168314
  14. 14

    The comorbidity landscape of 47,XXX syndrome: A nationwide epidemiologic study.

    Berglund A, Stochholm K, Gravholt CH

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(2)):475-487 doi:10.1016/j.gim.2021.10.012.

    PMID: 34906506
  15. 15

    Unravelling complex mosaicism of sex chromosomes in a patient with primary amenorrhea through cytogenetic analysis on urothelial cells.

    Sevilla-Montoya R, Zavaleta-Abreu MJ, Queipo G, et al.

    Taiwanese journal of obstetrics & gynecology 2021; (60(3)):526-529 doi:10.1016/j.tjog.2021.03.025.

    PMID: 33966741
  16. 16

    Discrepancies Between Sex Prediction and Fetal Sex After Prenatal Noninvasive Cell-Free DNA Screening.

    Witchel SF, Rajkovic A, Yatsenko SA

    Journal of the Endocrine Society 2025; (9(2)):bvaf007 doi:10.1210/jendso/bvaf007.

    PMID: 39881673
  17. 17

    Confined placental mosaicism and its impact on confirmation of NIPT results.

    Mardy A, Wapner RJ

    American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(2)):118-22 doi:10.1002/ajmg.c.31505.

    PMID: 27184347
  18. 18

    Confirmatory testing illustrates additional risks for structural sex chromosome abnormalities in fetuses with a non-invasive prenatal screen positive for monosomy X.

    Sund KL, Khattar D, Boomer T, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(2)):294-301 doi:10.1002/ajmg.c.31783.

    PMID: 32476283

This page provides educational information about Trisomy X genetics and prenatal screening. Always consult a genetic counselor or maternal-fetal medicine specialist to interpret your specific NIPT or diagnostic results.

Get notified when new evidence is published on Trisomy X syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.